<DOC>
	<DOCNO>NCT02440022</DOCNO>
	<brief_summary>This prospective , global , multicenter , randomize , control study design evaluate safety effectiveness Lutonix 035 AV Drug Coated Balloon PTA Catheter compare standard PTA Catheter treat subject present clinical hemodynamic abnormality native arteriovenous ( AV ) fistula locate upper extremity .</brief_summary>
	<brief_title>Study Comparing Lutonix AV Drug Coated Balloon v Standard Balloon Treatment Dysfunctional AV Fistulae</brief_title>
	<detailed_description />
	<mesh_term>Fistula</mesh_term>
	<mesh_term>Arteriovenous Fistula</mesh_term>
	<criteria>1 . Age ≥21 year ; 2 . The subject legally competent , informed nature , scope relevance study , voluntarily agree participation study 's provision , duly sign informed consent form ( ICF ) ; 3 . Arteriovenous fistula locate arm ; 4 . Native AV fistula create ≥30 day prior index procedure undergone one hemodialysis session ; 5 . Venous stenosis AV fistula target lesion locate anastomosis axillosubclavian junction abnormality attributable stenosis define K/DOQI guideline . ; 6 . Successful predilation target lesion percutaneous transluminal angioplasty ( PTA ) balloon ; 7 . Intended target lesion tandem lesion treat ≤120 mm DCBs length . 1 . Women pregnant , lactating , plan become pregnant study ; 2 . Hemodialysis access locate leg ; 3 . Subject two lesion access circuit ; 4 . Subject secondary nontarget lesion successfully treat ; 5 . Target lesion locate central axillosubclavian junction ; 6 . The subject secondary lesion locate central venous system ( central axillosubclavian junction ) ; 7 . A thrombosed access ; 8 . Surgical revision access site plan ; 9 . Recent prior surgical intervention access site ; 10 . Known contraindication ( include allergic reaction ) sensitivity iodinate contrast medium , adequately manage preand postprocedure medication ; 11 . Known contraindication ( include allergic reaction ) sensitivity paclitaxel . 12 . Subjects take immunosuppressive therapy routinely take ≥10mg prednisone per day ; 13 . Subject another medical condition , , opinion Investigator , may cause him/her noncompliant protocol confound data interpretation ; 14 . Subject life expectancy &lt; 12 month ; 15 . Anticipated kidney transplant ; 16 . Anticipated conversion peritoneal dialysis ; 17 . Subject stent locate target secondary non target lesion ; 18 . Subject infected AV access systemic infection ; 19 . Currently participate investigational drug , biologic , device study , previous enrollment study .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>